Lymphocyte-to-monocyte ratio predicts survival of patients with hepatocellular carcinoma after curative resection

World Journal of Gastroenterology

Volumn 21, Issue 38, 2015, Pages 10898-10906

  Lin, Ze Xiao ^a   Ruan, Dan Yun ^a   Li, Yang ^a   Wu, Dong Hao ^a   Ma, Xiao Kun ^a   Chen, Jie ^a   Chen, Zhan Hong ^a   Li, Xing ^a   Wang, Tian Tian ^a   Lin, Qu ^a   Wen, Jing Yun ^a   Wu, Xiang Yuan ^a  

^a THE THIRD AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

Author keywords

Hepatocellular carcinoma; Liver resection; Lymphocyte to monocyte ratio; Prognosis; Prognostic factor

Indexed keywords

BILIRUBIN;

ADULT; AREA UNDER THE CURVE; ARTICLE; BLOOD CELL COUNT; BLOOD CELL RATIO; CANCER PROGNOSIS; CANCER SURVIVAL; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER RESECTION; LYMPHOCYTE COUNT; LYMPHOCYTE TO MONOCYTE RATIO; MAJOR CLINICAL STUDY; MALE; MONOCYTE COUNT; OVERALL SURVIVAL; RECEIVER OPERATING CHARACTERISTIC; RECURRENCE FREE SURVIVAL; SURVIVAL RATE; SURVIVAL TIME; TUMOR VOLUME; BLOOD; CARCINOMA, HEPATOCELLULAR; DISEASE FREE SURVIVAL; LIVER NEOPLASMS; LYMPHOCYTE; MIDDLE AGED; MONOCYTE; MORTALITY; PREDICTIVE VALUE; PREOPERATIVE PERIOD; RETROSPECTIVE STUDY;

CARCINOMA, HEPATOCELLULAR; DISEASE-FREE SURVIVAL; FEMALE; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; LYMPHOCYTE COUNT; LYMPHOCYTES; MALE; MIDDLE AGED; MONOCYTES; PREDICTIVE VALUE OF TESTS; PREOPERATIVE PERIOD; RETROSPECTIVE STUDIES; ROC CURVE; SURVIVAL RATE;

EID: 84944112128     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v21.i38.10898     Document Type: Article

References (31)

1. Sherman M. Hepatocellular carcinoma: epidemiology, surveillance, and diagnosis. Semin Liver Dis 2010; 30: 3-16 [PMID: 20175029 DOI: 10.1055/s-0030-1247128]
2. Bruix J, Sherman M. Management of hepatocellular carcinoma: an update. Hepatology 2011; 53: 1020-1022 [PMID: 21374666 DOI: 10.1002/hep.24199]
3. Imamura H, Matsuyama Y, Tanaka E, Ohkubo T, Hasegawa K, Miyagawa S, Sugawara Y, Minagawa M, Takayama T, Kawasaki S, Makuuchi M. Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy. J Hepatol 2003; 38: 200-207 [PMID: 12547409 DOI: 10.1016/S0168-8278(02)00360-4]
4. Gluer AM, Cocco N, Laurence JM, Johnston ES, Hollands MJ, Pleass HC, Richardson AJ, Lam VW. Systematic review of actual 10-year survival following resection for hepatocellular carcinoma. HPB (Oxford) 2012; 14: 285-290 [PMID: 22487065 DOI: 10.1111/j.1477-2574.2012.00446.x]
5. Shah SA, Cleary SP, Wei AC, Yang I, Taylor BR, Hemming AW, Langer B, Grant DR, Greig PD, Gallinger S. Recurrence after liver resection for hepatocellular carcinoma: risk factors, treatment, and outcomes. Surgery 2007; 141: 330-339 [PMID: 17349844 DOI: 10.1016/j.surg.2006.06.028]
6. Sumie S, Kuromatsu R, Okuda K, Ando E, Takata A, Fukushima N, Watanabe Y, Kojiro M, Sata M. Microvascular invasion in patients with hepatocellular carcinoma and its predictable clinicopathological factors. Ann Surg Oncol 2008; 15: 1375-1382 [PMID: 18324443 DOI: 10.1245/s10434-008-9846-9]
7. Allavena P, Sica A, Solinas G, Porta C, Mantovani A. The infammatory micro-environment in tumor progression: the role of tumor-associated macrophages. Crit Rev Oncol Hematol 2008; 66: 1-9 [PMID: 17913510 DOI: 10.1016/j.critrevonc.2007.07.004]
8. Unitt E, Marshall A, Gelson W, Rushbrook SM, Davies S, Vowler SL, Morris LS, Coleman N, Alexander GJ. Tumour lymphocytic infiltrate and recurrence of hepatocellular carcinoma following liver transplantation. J Hepatol 2006; 45: 246-253 [PMID: 16580084 DOI: 10.1016/j.jhep.2005.12.027]
9. Gao Q, Qiu SJ, Fan J, Zhou J, Wang XY, Xiao YS, Xu Y, Li YW, Tang ZY. Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection. J Clin Oncol 2007; 25: 2586-2593 [PMID: 17577038 DOI: 10.1200/JCO.2006.09.4565]
10. Chen KJ, Zhou L, Xie HY, Ahmed TE, Feng XW, Zheng SS. Intratumoral regulatory T cells alone or in combination with cytotoxic T cells predict prognosis of hepatocellular carcinoma after resection. Med Oncol 2012; 29: 1817-1826 [PMID: 21678026 DOI: 10.1007/s12032-011-0006-x]
11. Peng SH, Deng H, Yang JF, Xie PP, Li C, Li H, Feng DY. Signifcance and relationship between infltrating infammatory cell and tumor angiogenesis in hepatocellular carcinoma tissues. World J Gastroenterol 2005; 11: 6521-6524 [PMID: 16425427]
12. Wu K, Kryczek I, Chen L, Zou W, Welling TH. Kupffer cell suppression of CD8+ T cells in human hepatocellular carcinoma is mediated by B7-H1/programmed death-1 interactions. Cancer Res 2009; 69: 8067-8075 [PMID: 19826049 DOI: 10.1158/0008-5472. CAN-09-0901]
13. Zhou J, Ding T, Pan W, Zhu LY, Li L, Zheng L. Increased intratu-moral regulatory T cells are related to intratumoral macrophages and poor prognosis in hepatocellular carcinoma patients. Int J Cancer 2009; 125: 1640-1648 [PMID: 19569243 DOI: 10.1002/ijc.24556]
14. Mano Y, Aishima S, Fujita N, Tanaka Y, Kubo Y, Motomura T, Taketomi A, Shirabe K, Maehara Y, Oda Y. Tumor-associated macrophage promotes tumor progression via STAT3 signaling in hepatocellular carcinoma. Pathobiology 2013; 80: 146-154 [PMID: 23364389 DOI: 10.1159/000346196]
15. Zhu XD, Zhang JB, Zhuang PY, Zhu HG, Zhang W, Xiong YQ, Wu WZ, Wang L, Tang ZY, Sun HC. High expression of macrophage colony-stimulating factor in peritumoral liver tissue is associated with poor survival after curative resection of hepatocellular carcinoma. J Clin Oncol 2008; 26: 2707-2716 [PMID: 18509183 DOI: 10.1200/JCO.2007.15.6521]
16. Kong LQ, Zhu XD, Xu HX, Zhang JB, Lu L, Wang WQ, Zhang QB, Wu WZ, Wang L, Fan J, Tang ZY, Sun HC. The clinical signifcance of the CD163+ and CD68+ macrophages in patients with hepatocellular carcinoma. PLoS One 2013; 8: e59771 [PMID: 23555776 DOI: 10.1371/journal.pone.0059771]
17. Sasaki A, Iwashita Y, Shibata K, Matsumoto T, Ohta M, Kitano S. Prognostic value of preoperative peripheral blood monocyte count in patients with hepatocellular carcinoma. Surgery 2006; 139: 755-764 [PMID: 16782430]
18. Shen SL, Fu SJ, Huang XQ, Chen B, Kuang M, Li SQ, Hua YP, Liang LJ, Peng BG. Elevated preoperative peripheral blood monocyte count predicts poor prognosis for hepatocellular carcinoma after curative resection. BMC Cancer 2014; 14: 744 [PMID: 25280428 DOI: 10.1186/1471-2407-14-744]
19. Porrata LF, Ristow K, Colgan JP, Habermann TM, Witzig TE, Inwards DJ, Ansell SM, Micallef IN, Johnston PB, Nowakowski GS, Thompson C, Markovic SN. Peripheral blood lymphocyte/monocyte ratio at diagnosis and survival in classical Hodgkin's lymphoma. Haematologica 2012; 97: 262-269 [PMID: 21993683 DOI: 10.3324/haematol.2011.050138]
20. Li ZM, Huang JJ, Xia Y, Sun J, Huang Y, Wang Y, Zhu YJ, Li YJ, Zhao W, Wei WX, Lin T Y, Huang HQ, Jiang WQ. Blood lymphocyte-to-monocyte ratio identifies high-risk patients in diffuse large B-cell lymphoma treated with R-CHOP. PLoS One 2012; 7: e41658 [PMID: 22911837 DOI: 10.1371/journal.pone.0041658]
21. Stotz M, Pichler M, Absenger G, Szkandera J, Arminger F, Schaberl-Moser R, Samonigg H, Stojakovic T, Gerger A. The preoperative lymphocyte to monocyte ratio predicts clinical outcome in patients with stage III colon cancer. Br J Cancer 2014; 110: 435-440 [PMID: 24357796 DOI: 10.1038/bjc.2013.785]
22. Li J, Jiang R, Liu WS, Liu Q, Xu M, Feng QS, Chen LZ, Bei JX, Chen MY, Zeng YX. A large cohort study reveals the association of elevated peripheral blood lymphocyte-to-monocyte ratio with favorable prognosis in nasopharyngeal carcinoma. PLoS One 2013; 8: e83069 [PMID: 24386144 DOI: 10.1371/journal.pone.0083069]
23. Hu P, Shen H, Wang G, Zhang P, Liu Q, Du J. Prognostic significance of systemic inflammation-based lymphocyte-monocyte ratio in patients with lung cancer: based on a large cohort study. PLoS One 2014; 9: e108062 [PMID: 25275631 DOI: 10.1371/journal.pone.0108062]
24. Ni XJ, Zhang XL, Ou-Yang QW, Qian GW, Wang L, Chen S, Jiang YZ, Zuo WJ, Wu J, Hu X, Shao ZM. An elevated peripheral blood lymphocyte-to-monocyte ratio predicts favorable response and prognosis in locally advanced breast cancer following neoadjuvant chemotherapy. PLoS One 2014; 9: e111886 [PMID: 25372468 DOI: 10.1371/journal.pone.0111886]
25. Zhou X, Du Y, Xu J, Huang Z, Qiu T, Wang X, Qian J, Zhu W, Liu P. The preoperative lymphocyte to monocyte ratio predicts clinical outcomes in patients with stage II/III gastric cancer. Tumour Biol 2014; 35: 11659-11666 [PMID: 25139101 DOI: 10.1007/s13277-014-2504-x]
26. Omata M, Lesmana LA, Tateishi R, Chen PJ, Lin SM, Yoshida H, Kudo M, Lee JM, Choi BI, Poon RT, Shiina S, Cheng AL, Jia JD, Obi S, Han KH, Jafri W, Chow P, Lim SG, Chawla YK, Budihusodo U, Gani RA, Lesmana CR, Putranto TA, Liaw YF, Sarin SK. Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma. Hepatol Int 2010; 4: 439-474 [PMID: 20827404 DOI: 10.1007/s12072-010-9165-7]
27. Oh BS, Jang JW, Kwon JH, You CR, Chung KW, Kay CS, Jung HS, Lee S. Prognostic value of C-reactive protein and neutrophil-to-lymphocyte ratio in patients with hepatocellular carcinoma. BMC Cancer 2013; 13: 78 [PMID: 23409924 DOI: 10.1186/1471-2407-13-7]
28. Mano Y, Shirabe K, Yamashita Y, Harimoto N, Tsujita E, Takeishi K, Aishima S, Ikegami T, Yoshizumi T, Yamanaka T, Maehara Y. Preoperative neutrophil-to-lymphocyte ratio is a predictor of survival after hepatectomy for hepatocellular carcinoma: a retrospective analysis. Ann Surg 2013; 258: 301-305 [PMID: 23774313 DOI: 10.1097/SLA.0b013e318297ad6b]
29. Fu SJ, Shen SL, Li SQ, Hua YP, Hu WJ, Liang LJ, Peng BG. Prognostic value of preoperative peripheral neutrophil-to-lymphocyte ratio in patients with HBV-associated hepatocellular carcinoma after radical hepatectomy. Med Oncol 2013; 30: 721 [PMID: 24026659 DOI: 10.1007/s12032-013-0721-6]
30. Templeton AJ, McNamara MG, Šeruga B, Vera-Badillo FE, Aneja P, Ocaña A, Leibowitz-Amit R, Sonpavde G, Knox JJ, Tran B, Tannock IF, Amir E. Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. J Natl Cancer Inst 2014; 106: dju124 [PMID: 24875653 DOI: 10.1093/jnci/dju124]
31. Gabrilovich DI, Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol 2009; 9: 162-174 [PMID: 19197294 DOI: 10.1038/nri2506]